MPT MEDICAL PROPERTIES TRUST INC
Real Estate Investment Trusts · NYSE · SEC CIK 1287865 · Fiscal year ends 12/31
Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.5%
TTM net income YoY92.4%
TTM EPS YoY92.4%
Revenue 3-yr CAGR-12.3%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin-12.6%
FCF margin—
EBITDA margin—
Returns
ROE-2.7%
ROA-0.9%
ROIC (approx.)—
Asset turnover0.07x
Leverage & solvency
Liabilities / assets69.2%
Debt / equity2.13x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income-1.72x
Accruals ratio-2.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $972.02M | $995.55M | $871.80M | $1.54B | $1.54B |
| Cost of revenue | $90.31M | $74.17M | $110.07M | $167.42M | $101.44M |
| SG&A expense | $130.43M | $133.79M | $145.59M | $160.49M | $145.64M |
| Interest expense | $510.36M | $417.82M | $411.17M | $359.04M | $367.39M |
| Pretax income | -$237.32M | -$2.36B | -$686.77M | $959.72M | $730.89M |
| Income tax | $38.62M | $44.10M | -$130.68M | $55.90M | $73.95M |
| Net income | -$277.05M | -$2.41B | -$556.48M | $902.60M | $656.02M |
| EPS (basic) | -0.46 | -4.02 | -0.93 | 1.50 | 1.11 |
| EPS (diluted) | -0.46 | -4.02 | -0.93 | 1.50 | 1.11 |
| Dividends declared per share | 0.33 | 0.46 | 0.88 | 1.16 | 1.12 |
| Weighted avg. shares (diluted) | 600.89M | 600.25M | 598.52M | 598.84M | 590.14M |
| Balance sheet | |||||
| Cash & equivalents | $540.86M | $332.33M | $250.02M | $235.67M | $459.23M |
| Total assets | $15.00B | $14.29B | $18.30B | $19.66B | $20.52B |
| Long-term debt | $9.70B | $8.85B | $10.06B | $10.27B | $11.28B |
| Total debt | $9.70B | $8.85B | $10.06B | $10.27B | $11.28B |
| Total liabilities | $10.39B | $9.46B | $10.67B | $11.06B | $12.07B |
| Shareholders' equity | $4.61B | $4.83B | $7.63B | $8.59B | $8.44B |
| Net debt | $9.16B | $8.52B | $9.81B | $10.03B | $10.82B |
| Shares outstanding | 597.01M | 600.40M | 598.99M | 597.48M | 596.75M |
| Cash flow statement | |||||
| Operating cash flow | $230.77M | $245.48M | $505.79M | $739.01M | $811.66M |
| Investing cash flow | -$264.74M | $1.32B | $517.56M | $396.06M | -$3.86B |
| Financing cash flow | $228.08M | -$1.48B | -$1.02B | -$1.34B | $2.95B |
| Depreciation & amortization | $272.82M | $453.75M | $616.13M | $345.58M | $333.78M |
| Stock-based compensation | $25.75M | $32.98M | $33.25M | $49.42M | $52.11M |
| Share buybacks | $23.44M | — | — | $17.94M | — |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.